Le Lézard
Classified in: Science and technology, Business
Subjects: PER, CXP

AEgis Technologies Announces New Leadership Roles


ARLINGTON, Va., Feb. 6, 2020 /PRNewswire/ -- AEgis Technologies Group (AEgis), Arlington Capital Partner's most recent National Security Platform, announces today several leadership appointments to posture the company for future growth and execution at scale. James Batt, 30-year career in National Security missions, will join the platform as Corporate Executive Vice President for Business Development. Pat Cannon, formerly Vice President of AEgis' Distributed Operations Division, has been promoted to Sector President and General Manager and Lance Cooper, former AEgis strategy executive, will expand and elevate his role as Corporate Senior Vice President of Government Operations.

"We have exciting plans for the AEgis platform and being able to both promote talent from within the organization in Pat and Lance into areas of responsible charge and augment with first class external talent in James to drive our future growth and expansion is phenomenal," said Jonathan Moneymaker, Chief Executive Officer. "The experience, leadership, and integrity of this team exemplifies that of all our employees and is the foundation of why our teams are known for being our customer's trusted partners for delivering critical mission capability."

In Mr. Batt's role he will have responsibility for overall Platform-wide growth and strategic alignment to the company's markets of focus. Mr. Cannon, in his new role, will be responsible for ensuring flawless customer delivery and organic expansion for the AEgis' Sector programs throughout the United States. Mr. Cooper will head efforts related to advancing the company's interests, competitiveness, and reputation across legislative and congressional influencers driving programmatic expansion through insight on budgetary, acquisition, and legislative alignment.

"At AEgis, our calling is leading the transformation of modern warfare and it's fantastic to be getting off to such a great start." added Moneymaker.

About AEgis Technologies Group
The AEgis Technologies Group (AEgis) provides advanced engineering solutions across the space superiority, directed energy, missile defense, electronic warfare & cyber, C4ISR, and intelligence markets. The Company was founded in 1989 and has served its core customer base as a trusted partner for decades focused on solving the Defense and National Security Community's hardest challenges. AEgis is an end to end lifecycle partner through R&D, development, and into operations. We are the trusted provider leading the transformation for tomorrow's multi-model and multi-domain warfare.

www.AEgisTG.com

SOURCE AEgis Technologies Group


These press releases may also interest you

at 23:14
As the graduation season approaches, COOFANDY, the modern men's essentials designer, is rolling out the red carpet for graduates with its "Style for Celebrations" theme. The brand encourages participants to share their graduation highlights using...

at 23:05
AI is the CIO's top priority, according to findings of Lenovo's third annual global CIO report. Inside the Tornado: How AI is Reshaping Corporate IT Today, reveals that while CIOs need to adopt and scale AI urgently, their ambitions are threatened by...

at 23:00
OPUS, the opportunity community for business builders, today announces a partnership with leading Dubai-based think-tank, Fiker Institute, as it launches in the...

at 23:00
Amkan Ventures, officially launched today and is announcing a $10M Fund of Funds (FoF) dedicated to backing emerging venture managers in the US. The new FoF is building a portfolio of a dozen funds across tech-enabled industries. Amkan Ventures...

at 22:33
The report titled "Building Energy Management Systems Market by Component (Hardware, Services, Software), Type (Integrated Building Energy Management Systems, Standalone Building Energy Management Systems), Application, Deployment Mode, End-Use -...

at 22:15
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...



News published on and distributed by: